Physician profile
Sona Salahuddin
NPI 1649997404
$755.16
in general payments reported to CMS, 2019-2025
14 companies · $664 in 2025
The $664 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $91.66 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $184.23 | 2025 | Lifevest |
| Abbott Laboratories | $106.84 | 2025 | Jot Dx |
| Novartis Pharmaceuticals Corporation | $74.19 | 2024-2025 | |
| Novo Nordisk INC | $60.98 | 2025 | Wegovy |
| Amgen INC. | $59.83 | 2025 | Repatha, Repatha |
| Bridgebio Pharma, INC. | $50.99 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $45.63 | 2024-2025 | Verquvo |
| Bard Peripheral Vascular, INC. | $45.51 | 2025 | Venclose Maven Catheter |
| Edwards Lifesciences Corporation | $35.53 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $23.23 | 2025 | Bodyguardian |
| Janssen Pharmaceuticals, INC | $22.76 | 2024 | Xarelto |
| Lilly USA, LLC | $18.14 | 2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.88 | 2025 | Jardiance |
| Vivaquant INC, Dba Rhythm Express | $9.42 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sona Salahuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.